Germaine Laboratories

What Germaine Laboratories does

Germaine Laboratories, Inc. is an FDA-registered manufacturer and supplier of in vitro diagnostic tests and related laboratory services, operating from its ISO 13485:2016-certified facility in San Antonio, Texas. Founded in 1990 and incorporated in 1997, the company sells a portfolio of 150+ products organized under sub-brands including AimStrip (urinalysis strips, hemoglobin testing, pregnancy tests), AimTab (tablet-based glucose and ketone tests), SafeCup and AimScreen (on-site drug screening cups), StrepAim, BioSign (flu tests), Flowflex (COVID-19 antigen tests), Compliance Gold, AccuHome, and VQPet H (veterinary blood glucose). Underlying technology includes immunoassay screening, gas chromatography/mass spectrometry (GC/MS) confirmation testing, reflectance photometry for hemoglobin measurement, and automated urine analyzers with EMR export capabilities; all manufacturing occurs under cGMP as overseen by the FDA.

The company monetizes through four distinct streams. The primary stream is one-time sale of diagnostic test products to a global network of distributors and via direct e-commerce on germainelabs.com, with publicly disclosed unit pricing across categories. A second stream consists of professional laboratory services — SAMHSA-certified (since March 26, 1999) drug-of-abuse testing including specimen transport, customized screening panels, GC/MS confirmation, and Medical Review Officer review — sold to drug courts, criminal justice entities, employers, and school districts with rapid turnaround (over 80% of negative results reported before 8:00 am CST). A third stream is small-scale cGMP contract tableting manufacturing for clients requiring formulation, manufacturing, and packaging under Title 21 CFR Part 11. A fourth stream is private labeling and OEM packaging that enables distributors to sell Germaine-manufactured products under their own brands.

Customers span four verticals: medical (physician offices, walk-in clinics, pharmacies), drug testing (workplaces, schools, drug courts, criminal justice), food & beverage (glucose testing in wine, candy, and other products), and veterinary (animal hospitals and clinics). Go-to-market combines a channel-partner model (bulk/OEM packaging and private labeling through distributors in the US and worldwide), sales-led engagements for customized employer and drug court testing programs, and direct-to-consumer e-commerce with transparent pricing and account-based ordering. The company is privately held with no disclosed investors, funding rounds, or M&A activity.

Name

Germaine Laboratories

Legal name

Germaine Laboratories, Inc.

Website

https://germainelabs.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Germaine Laboratories is an FDA-registered, ISO 13485:2016-certified manufacturer of in vitro diagnostic tests based in San Antonio, Texas, serving medical, drug testing, food & beverage, and veterinary customers through a global distributor network, direct e-commerce, SAMHSA-certified laboratory services, and contract tableting manufacturing.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

Keywords

• In vitro diagnostics
• Rapid diagnostic tests
• Drug testing supplies
• Urinalysis reagent strips
• Point of care testing

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Diagnostic Test Products: Sale of rapid diagnostic test products including pregnancy tests, urinalysis strips, drug tests, hemoglobin tests, COVID-19 tests, and related supplies. Products sold in various pack sizes to distributors and end-users.
2. Laboratory Testing Services: Contract laboratory services for drugs of abuse testing including specimen collection, screening, GC/MS confirmation, Medical Review Officer (MRO) review, and customized reporting. Services major employers, school districts, criminal justice and drug court entities.
3. Contract Tableting Manufacturing: Small-scale contract tableting manufacturing services for clients with tableting needs. Provides full development support from clinical development to cGMP manufacturing.
4. Private Labeling and OEM: Custom labeling and packaging services allowing distributors to sell Germaine products under their own brand names. Bulk packaging options available.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Germaine Laboratories develops, manufactures, and supplies FDA-registered in vitro diagnostic (IVD) test kits and analyzers — including urine reagent strips, hemoglobin tests, drug screening cups, rapid strep, COVID-19 and flu antigen tests, pregnancy tests, and veterinary glucose monitors — sold through a global distributor network and direct e-commerce. The company also operates a SAMHSA-certified contract laboratory providing drugs-of-abuse testing services with GC/MS confirmation and offers cGMP-compliant tableting contract manufacturing.

Product overview

Germaine Laboratories is an FDA-registered manufacturer of in vitro diagnostic tests operating since 1990. The company offers a comprehensive portfolio of diagnostic products across multiple sub-brands: AimStrip® (urinalysis strips, hemoglobin testing, pregnancy tests), AimTab™ (tablet-based tests for glucose and ketones), AimScreen™ and SafeCup™ (on-site drug screening), StrepAim® (strep throat tests), BioSign® (flu tests), Flowflex™ (COVID-19 tests), and VQPet H (veterinary glucose monitoring). The product line also includes AccuHome® for OTC consumer tests and Compliance Gold®. Beyond products, Germaine Laboratories provides SAMHSA-certified laboratory drug testing services with GC/MS confirmation, and cGMP-compliant tableting contract manufacturing services. The company serves medical, drug testing, food & beverage, and veterinary industries through a distributor network.

Differentiator

Problem solved

Functional benefit

Brands

• AccuHome®: Brand for pregnancy and ovulation diagnostic tests
• AimTab™
• Aim™
• AimScreen™
• AimStep®
• AimStrip®
• Compliance Gold®
• SafeCup™
• StrepAim®
• VQPet H
• Flowflex™
• BioSign®

Products and services

• AimStrip® Urinalysis (reagent strips and AimStrip Urine Analyzer 2)

Quantifiable outcome

• Over 80% of negative results reported before 8:00 am CST; All negative results before 1:00 pm CST
• +1 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Sekisui Diagnostics: Broader clinical chemistry and immunoassay diagnostics incumbent with overlapping offerings in urinalysis, clinical chemistry, and drug screening reagents. Serves the same clinical laboratory and physician-office end markets at materially larger scale.
• OraSure Technologies: Broader diagnostics incumbent focused on oral fluid and rapid infectious disease testing. Competes in overlapping drug-testing and infectious-disease segments with greater scale and public-market access, but a narrower product focus than Germaine's full IVD catalog.
• QuidelOrtho: Large IVD incumbent offering rapid immunoassay, urinalysis, and infectious disease products. Overlaps with Germaine's AimStrip urinalysis and BioSign flu lines but at substantially greater scale with broader distribution and hospital-channel reach.

Direct peers

• Alfa Scientific Designs: Direct competitor manufacturing rapid diagnostic tests including drug screening, pregnancy, and urinalysis strips under cGMP with FDA registration. Similar private-label/OEM business model targeting US distributors.
• Healgen Scientific: Direct competitor in point-of-care drugs-of-abuse screening, pregnancy, and infectious disease rapid tests. Operates FDA-registered manufacturing with a global distributor network serving workplace, criminal justice, and clinical customers with overlapping SKU categories.
• BTNX: Rapid diagnostic test manufacturer with overlapping product categories (drugs of abuse, pregnancy, infectious disease). Operates FDA-registered manufacturing and serves similar distributor and clinical channels in North America.
• ACON Laboratories: Direct competitor in rapid diagnostic tests (pregnancy, drug of abuse, urinalysis, infectious disease). ACON's Flowflex brand is in fact the OEM product distributed by Germaine, and ACON operates a similar FDA-registered, ISO 13485-certified manufacturing model with global distribution and private-label capabilities.
• Premier Biotech: Direct peer in workplace and clinical drugs-of-abuse testing products, including oral fluid and urine screening devices sold through distributors. Operates in the same SAMHSA-aligned end markets with comparable product positioning.
• CLIAwaived Inc. Distributor and reseller of CLIA-waived rapid diagnostics including drug testing, urinalysis, and point-of-care tests from multiple manufacturers. Comparable distribution-and-services model for physician office labs and workplace testing programs.
• Atlas Medical: Direct peer offering rapid diagnostic tests across drugs of abuse, pregnancy, infectious disease, and clinical chemistry. Targets similar distributor and laboratory customers with comparable private-label capabilities.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Germaine Laboratories